A: Duke is collaborating with Deerfield, an investment firm dedicated to advancing healthcare, to accelerate
the translation of research in Duke faculty laboratories into clinical therapeutics. Four Points is a Deerfield
company that will support Duke’s innovative translational research and leverage Deerfield’s expertise in
accelerating state-of-the-art drug development. Four Points will fund projects with the aim of discovering
novel therapeutics to cure life-altering diseases.
Through Four Points, Deerfield has committed up to $130 million in initial funding to support promising Duke translational research. This collaboration will provide operational support and may make additional capital investments into spin-off companies that emerge from Four Points projects that show commercial potential.
A: Principal Investigators whose principal employer is Duke University or Duke University Health System or who have a faculty appointment at Duke University and are therefore subject to Duke’s institutional policies are eligible to apply.Q: HOW CAN I APPLY?
A: To submit an application, please register here to create a Four Points profile. Details will follow.Q: DOES FOUR POINTS HAVE A THERAPEUTIC AREA OF INTEREST?
A: No – We welcome applications from all therapeutic areas.Q: HOW MANY CALLS FOR PROPOSAL ARE THERE IN A YEAR?
A: There will be at least one call for proposals per calendar year.